Mizuho weighs in on Humana (HUM) after it lost MA stars lawsuit
Tweet Send to a Friend
Mizuho analyst Ann Hynes reiterated an Outperform rating and $316.00 price target on Humana (NYSE: HUM) after the company lost ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
